Also known as atopic dermatitis, eczema is an inflammatory, chronically relapsing and pruritic skin disorder that affects a large percentage of humans, particularly young children (10-20%). Atopic dermatitis most often begins in childhood before age 5 and may persist into adulthood.
During the last 2 years, CeNTI collaborated in a project named “2nd Dermis”, with the industrial promoter Crispim Abreu and several research partners, such as: Faculty of Medicine of the University of Porto, School of Biotechnology of the Catholic University, CITEVE and Faculty of Pharmacy of the University of Porto. This work group joined efforts to develop a textile based on 100% organic cotton, coated with a natural polysaccharide for controlling and preventing eczema. CeNTI focused on the functionalization of textiles through innovative and sustainable processes.
According to the results of the in vitro studies, the natural polysaccharide proved to be effective in the reduction of bacteria proliferation, including S. aureus. This antibacterial agent is a natural component, already used in other fields of medicine such as the treatment of burns and surgical wounds.
The results were presented to public last week, on the 18th November, and a 2nd stage of in vivo studies are about to start, focused on an evidence-based clinical trial, with a group of about 200 patients.
See more information here: